These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 20458439
1. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R. Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439 [Abstract] [Full Text] [Related]
2. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250 [Abstract] [Full Text] [Related]
3. Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study. Paniccia R, Antonucci E, Maggini N, Miranda M, Romano E, Gori AM, Marcucci R, Prisco D, Abbate R. Ther Drug Monit; 2011 Feb; 33(1):94-8. PubMed ID: 21192314 [Abstract] [Full Text] [Related]
4. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818 [Abstract] [Full Text] [Related]
5. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896 [Abstract] [Full Text] [Related]
6. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. J Am Coll Cardiol; 2009 Mar 10; 53(10):849-56. PubMed ID: 19264241 [Abstract] [Full Text] [Related]
7. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF, Abbate R, Gori AM. Thromb Haemost; 2008 May 10; 99(5):930-5. PubMed ID: 18449424 [Abstract] [Full Text] [Related]
8. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Paniccia R, Antonucci E, Maggini N, Romano E, Gori AM, Marcucci R, Prisco D, Abbate R. Am J Clin Pathol; 2009 Jun 10; 131(6):834-42. PubMed ID: 19461090 [Abstract] [Full Text] [Related]
9. Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry. von Beckerath N, Sibbing D, Jawansky S, Braun S, Morath T, Vogt W, Schömig A, Kastrati A. Blood Coagul Fibrinolysis; 2010 Jan 10; 21(1):46-52. PubMed ID: 19823079 [Abstract] [Full Text] [Related]
10. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF. Circulation; 2009 Jan 20; 119(2):237-42. PubMed ID: 19118249 [Abstract] [Full Text] [Related]
11. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. Thromb Haemost; 2010 Jan 20; 103(1):151-9. PubMed ID: 20062919 [Abstract] [Full Text] [Related]
13. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N. Thromb Haemost; 2008 Jan 20; 99(1):121-6. PubMed ID: 18217143 [Abstract] [Full Text] [Related]
15. Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition. Aradi D, Magyarlaki T, Tokés-Füzesi M, Rideg O, Vorobcsuk A, Komócsi A. Platelets; 2010 Jan 20; 21(7):563-70. PubMed ID: 20642320 [Abstract] [Full Text] [Related]
18. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study. Mangiacapra F, Patti G, Barbato E, Peace AJ, Ricottini E, Vizzi V, Gatto L, D'Ambrosio A, De Bruyne B, Wijns W, Di Sciascio G. JACC Cardiovasc Interv; 2012 Mar 20; 5(3):281-9. PubMed ID: 22440493 [Abstract] [Full Text] [Related]
19. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG. Thromb Haemost; 2008 Nov 20; 100(5):829-38. PubMed ID: 18989527 [Abstract] [Full Text] [Related]
20. Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry. Lordkipanidzé M, Pharand C, Schampaert E, Palisaitis DA, Diodati JG. Thromb Res; 2009 Sep 20; 124(4):418-22. PubMed ID: 19250657 [Abstract] [Full Text] [Related] Page: [Next] [New Search]